Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening-Reference-Cited by-同舟云学术

Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening

Published:2022-03-23 Issue:6 Volume:96 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Primadharsini Putu Prathiwi¹^ORCID,Nagashima Shigeo¹^ORCID,Nishiyama Takashi²^ORCID,Takahashi Masaharu¹^ORCID,Murata Kazumoto¹^ORCID,Okamoto Hiroaki¹^ORCID

Affiliation:

1. Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Tochigi, Japan

2. Laboratory for Drug Target Research, Integrated Bioscience Division, Institute of Agriculture, Shinshu University, Nagano, Japan

Abstract

Bioluminescent reporter viruses are essential tools in molecular virological research. They have been widely used to investigate viral life cycles and in the development of antiviral drugs.

Funder

Japan Agency for Medical Research and Development

MEXT | Japan Society for the Promotion of Science

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jvi.01906-21

Reference64 articles.

1. Update: proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A)

2. Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome